You are on page 1of 5

GENOMIC WIDE ASSOCIATION STUDY FOR

HYPERTENSION
ZENOVIA ANDREI1
1
Lucian Blaga University, Faculty of Medicine
………………………………………………………………………………….

* Corresponding author: zenovia.andrei@gmail.com

Abstract: The abstract should be an objective representation of the article, it must not contain results
that are not presented and substantiated in the main text and should not exaggerate the main
conclusions. The abstract should be between 200 to 300 words maximum. Click
Abstract and keywords with font Times New Roman, 12 Italic

Keywords: keyword 1, keyword 2, keyword 3,........


3 to 7 words, be separated by commas and not to exceed 1 line

1. Introduction
The journal only publishes novel, high-quality original research papers. Special issues of selected,
peer-reviewed papers from scientific meetings, workshops, conferences on the science, technology
and, engineering and emergent subjects will be also published.
The introduction will contain, clearly and concisely, the selective presentation of the scientific
information concerning the subject as a support for the original elements of the paper.
This paper template, created in MS Word, provides authors with most of the formatting specifications
needed for preparing electronic versions of their contributions. All standard components have been
specified for the reasons to easer use when formatting individual paper which facilitates the electronic
processing, and the conformity of the journal style. Margins, line spacing, and type styles are included;
examples of the type styles are provided throughout this document and are identified in red color.
Some components, such as multi-leveled equations, schema, etc. are not prescribed, although a few
various styles are provided. The authors will need to incorporate applicable criteria that follow.

2. Materials and Methods


2.1. Study population
Subjects included in this study were male and female patients admitted between 2008 and 2012 to two
clinics in Bucharest Urology Clinic ‘Th. Burghele’ and General Surgery Clinic „Sf. Maria” for various
medical conditions. All subjects gave written informed consent prior to enrolment and accepted the use
of personal and clinical data and biological samples for genetic research. The Bioethical Committee of
the Romanian College of Physicians approved the study and the study protocols were approved by the
National Ethical Board of the Romanian Medical Doctors Association in Romania. Trained
interviewers performed face-to-face interviews, using standardized questionnaires, to collect personal
data (ethnicity, marital status, education, height and weight), lifestyle data (occupation, smoking,
coffee and tea consumption) and medical history (personal and familial). All subjects were of self-
reported European descent. No significant difference was observed between the average age of the
cases (66.9) and controls (64.3)
2.2. Genotyping and analysis of Single-Nucleotide Polymorphism (SNP) data
DNA was extracted from whole blood at deCODE Genetics (Reykjavik, Iceland) and genotyped using
Infinium OmniExpress-24 bead chips (Illumina). A total of 716,503 SNPs were genotyped for each
individual included in the study. The genotype data were filtered using Plink! v1.07 15. Approximately
10% of the SNPs genotyped were removed using a Hardy–Weinberg equilibrium significance
threshold of 5 × 10-6 and by excluding markers with a minor allele frequency lower than 1%. Prior to
the imputation, each chromosome was phased in a single run using SHAPEIT 16. Markers from Phase
3 October 2014 of the 1000 Genomes 17 were imputed into the 2024 chip-typed individuals using the
IMPUTE2 software 18 with a posterior probability of 0.9 as a threshold to call genotypes. The set of
genotypes were tested for population heterogeneity using principal component analysis in the
ADMIXTURE software 19, and the results were consistent with a homogeneous population.

3. Results and Discussions (Head 3 – 14 Bold)


After an extensive search of the known literature, we have decided on the following as susceptible
genes that should be further studied in order to prove a link with hypertension.

3.1. GWAS Analysis

We report here a genome-wide association study (GWAS) for a complex trait, namely hypertension.
We performed an initial GWAS in cohort of the ROMCAN project combining data collected from
5385 individuals 78% males of Romanian descent out of which 38% where cases and 60% controls.
We identified 24 loci out of these 5 strongly associate with hypertension. Using bioinformatics, we
show that identified genes are enriched for expression in heart muscle myocytes and in pathways
relevant for hypertension, transmembrane transporter activity, arterial wall structure and regulation of
Ca2+ metabolism.
We explored the different complex physiopathology mechanisms that are known to cause hypertension
and then associated the identified loci with individual pathologic pathways that may cause the disease,
and then cross referenced our findings with published results of experimental work revolving around
this gene.
3.2. Genes with a strong association with hypertension
The gene ITPR2 is located on chromosome 12 has as its main function the coding for the receptor for
inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium.
ITPR2 has been shown to affect nutrient metabolism and central obesity. Dietary patterns, genetic
variants, and host characteristics. (Melkonian) Experimental reserch on transgenic mice with the high-
expressing IP3 receptor mild cardiac hypertophy by 3 months of age , and consistent with this
phenotype the reexpression of the hypertrophy -related genes atrial natriuretic factor and skeletal α-
actin were observed in the hearts of high-expressing IP3R mice, and no cardiac hypertrophy in the low-
expressing IP3 transgenic mice. (Nakayama)

3.3. Figures and Tables


For this table we have used the SNPs with a p-value of ~ 0.05 resulted from the data analysis with the
plink software and RStudio. After the identification of the SNPs, we conducted a search using the
National Center for Biotechnology Information and dbSNP database. After we discovered a link
between our SNPs and a GENE, we then conducted a search for the respective GENE in the
GeneCards®: The Human Gene Database and after we identified a link between the GENE and our
test hypothesis, we then conducted a search on the GWAS Catalog for further literature directed
review. We then searched for the genetic databases for signals of GENE expression in various human
tissues in order to discover any possible link to hypertension.

Table 1. Single-Nucleotide Polimorphism association with GWAS for Hypertension


Group Chromosome SNPs GENE Link to HTA
A 1 rs6657631 - Unknown
Group Chromosome SNPs GENE Link to HTA
rs2454228 - Unknown
rs6720101 PANTR1 BMI
2 rs10932355 - Unknown
rs11695055 DNER BMI
rs4684862 CNTN6 DBP
rs9845983 THRB Erythrocyte count
3
rs12489864 EPHA6 SBP
rs7621659 CPNE4 BMI
4 rs10013360 CCSER1 Unknown
B
5 rs891980 - Unknown
rs9493826 - Unknown
6 PDE7B Erythrocyte count
rs7747433
LOC644135 Intraocular pressure
Glomerular
7 rs10480299 PRKAG2
filtration rate
rs10755966 ZNF704 Unknown
8
rs1378900 LOC105375752 Waist/Hip ratio
9 rs7855735 LOC105376234 Brain Aneurysm
C
10 rs11253143 - Unknown
rs4539314 LRRC4C Unknown
Renal Carcinoma
rs640908 PLAAT3
11 Antigen
rs10502138 - Unknown
rs12799000 - Unknown
rs12368682 - Unknown
12
rs2230377 ITPR2 BMI; Waist / Hip
rs10507431 DCLK1 Unknown
13 Chronic Kidney
rs12585074 NALCN-AS1
Disease
D BMI
14 rs12435483 TRAF3
15 rs16952930 - Unknown
16 rs7505073 - Unknown
17 rs16952930 - Unknown
E
18 rs7505073 - Unknown
rs2305758 HAUS8 SBP; CVD
19
rs8104920 ZNF836 Unknown
F
rs1111036 LOC107985399 Unknown
20
rs6025161 - Unknown
21 rs914186 BACE2 BMI
G 0,3
22 rs3788310 TXNRD2 AKI
y = 0.0001x
0,25Diastolic blood
BMI: Body Mass Index; DBP: pressure;+SBP:
0.1678
Systolic blood pressure; CVD: Cardio Vascular Disease AKI: Acute
R2 = 0.9995Kidney injury
0,2
660 nm

0,15

0,1

0,05

0
0 0,001 0,002 0,003 0,004 0,005 0,006
concentration, g/L
Figure 1. Example of a figure caption (figure caption).
3.3. ……………..

4. Conclusions (Head 4 – 14 Bold)


The paper, written in English, will publish on the website as .pdf file, ONE COLUMN; it should better
between 4 and 12 pages. The article should be composed of the title, author(s), abstract, keywords,
introduction, materials and methods, results and discussion, conclusions, and references.

Acknowledgments: All sources of funding of the study paper should be disclosed, put sponsor
acknowledgments here.
Text with font Times New Roman, 12 Regular

References (Head 5 – 12 Bold)

The bibliographic references should be numbered in order of appearance and indicated by a numeral or
numerals in square brackets, e.g., [1] or [2,3], or [4–6].
Papers that have been accepted for publication should be cited as “in press”; it will be used only the
abbreviated journal name, according to Elsevier:
https://www.elsevier.com/__data/promis_misc/BMCL_Abbreviations.pdf
Please completely adapt your references as the following formats:
1. HELISSEY, P., GIORGI-RENAULT, S., RENAULT, J.J., Heterocyclic Quinones. XVI. :
Pharmacomodulation in the Series of 11H-Indolo[3, 2-c]quinolinediones : Synthesis, Cytotoxicity and
Antitumor Activity of 3-Substituted 11H-Pyrido[3', 4' : 4, 5]pyrrolo[3, 2-c]quinoline-1, 4-diones,
Chem. Pharm. Bull., 37(9), 1989, 2413-2416.
2. DOUKEH, R., BOMBOS, M., POPOVICI, D., PASARE, M., BOLOCAN, I., Effect of Support on
the Performance of CoMoRe Catalyst in Thiophene and Benzothiophene Hydrodesulfurization, Rev.
Chim., 70(1), 2019, 28-32.
3. PRASAD, A.S., Clinical, Biochemical and Nutritional Aspects of Trace Elements, Alan R. Liss,
Inc., New York, 2004, 5-15.
4. WRIGH, W., 1906, US Patent No. 821393.
5. MALIK, A.S., BOYKO, O., ATKAR, N., YOUNG, W.F., A comparative study of MR imaging
profile of titanium pedicle screws, Acta Radiologica, 42, 2001, 291-293.
https://doi.org/10.1080/028418501127346846
6. Title of website. Available online: URL (accessed on Day Month Year)
7. RADU, G.L., TACHE, A., Proceedings of the 6th Annual International Conference of Bioanalysis,
Bucharest, Romania, 1-5 September 2014, p.2758.
References with font Times New Roman, 12 Regular
Manuscript received: 11.10.2019
Paper Size: A4 Layout: Header=1cm; Footer=1cm
Margin: Top=2.5 cm; Bottom=2.5cm; Left=2cm; Right=1.5cm
All Font of paper: Size=12; Text=Regular; Align=Justify; Type=Times New Roman
Title: Size 18; Text=Bold; Align=Justify
Authors Name: Size=12; Text=Bold All Caps; Align=Justify
Authors Affiliation: Size=10; Text=Regular; Align=Justify
Abstract and Keywords: Size=12; Text=Italic, Regular; Align=Justify
Main Headings: Size=14; Text=Bold; Align=Justify; Capitatization=Sentence case
Subheadings: Size=12; Text=Bold; Align=Justify; Capitalization= Sentence Case
Acknowledgement: Size=12; Text=Regular; Align=Justify
Line Space: 1.Reference: Size=12; Text=Regular; Align=Justify

You might also like